Comparison of insulinotrophic actions of nateglinide with glibenclamide dissociated from absorption in conscious dogs

Metabolism: Clinical and Experimental

Volumn 51, Issue 5, 2002, Pages 575-581

  Okamoto, M ^a,b   Ogihara, N ^a,b   Kawamura, W ^a,b   Ebihara, S ^a,b   Takiguchi, K ^a,b   Morita, T ^a,b   Uchida, R ^a,b   Yamaguchi, J ^a,b   Sakai, T ^a,b   Okuda, Y ^a,b   Hayashi, Y ^a,b   Arakawa, Y ^a,b   Kikuchi, M ^a,b  

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; INSULIN; NATEGLINIDE; SULFONYLUREA RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTINUOUS INFUSION; CONTROLLED STUDY; DIET RESTRICTION; DOG; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FEMALE; GASTROINTESTINAL ABSORPTION; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; MALE; NONHUMAN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

EID: 0036252394     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.31981     Document Type: Article

References (37)

1. Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166
2. N-acylphenylalanines and related compounds. A new class of oral hypoglycemic agents
3. 3H] glibenclamide
4. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine
5. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N- (trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166)
6. ATP channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide
7. A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic beta-cells
8. 2+ influx
9. Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas
10. Stimulating activity of A-4166 on insulin release in in situ hamster pancreatic perfusion
11. Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals
12. 14C-labelled A-4166 in pancreatic islets
13. Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets
14. 3H-glibenclamide in pancreatic islet cells
15. Intracellular localization and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells
16. Interaction of sulfonylureas with pancreatic β-cells
17. Analysis of enantiomers of a new antidiabetic agent in plasma by high performance liquid chromatography
18. Separation of a new antidiabetic agent N-(trans-4-isopropylcyclo-hexylcarbonyl)-d phenylalanine and its isomers by chiral high-performance liquid chromatography
19. Escalating dose study of a novel non-SU agent, A-4166, in type 2 diabetes
20. Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans
21. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects
22. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets
23. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas
24. Oral hypoglycemic agents
25. The binding of sulphonylureas to serum albumin
26. New perspectives on the actions of sulphonylureas and hyperglycaemic sulphonamides on the pancreatic β-cells
27. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic β cells
28. 2+-dependent exocytosis in pancreatic β cells is mediated by a 65-kDa mdr-like P-glycoprotein
29. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes
30. Sulfonylureas enhance exocytosis from pancreatic β-cells by a mechanism that does not involve direct activation of protein kinase C
31. 2+ in response to glucose
32. Tolbutamide stimulation and inhibition of insulin release: Studies of the underlying ionic mechanisms in isolated rat islets
33. cAMP-GEFII is a direct target of cAMP in regulated exocytosis
34. ATP-channel-independent, secretion in rat pancreatic a- and β-cells
35. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line